BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Evexias BPC 157 People talk about BPC 157 like it's one thing. It isn't. Oral BPC 157 stays local. It survives digestion long enough to act on the GI mucosa, then clears before it reaches systemic circulation. BPC 157 ORAL Beverly Hills Rejuvenation Center BPC 157 Peptide Therapy Regenerative Medicine Dr. Henry Sobo, MD Peptide Therapy for Skin Rejuvenation LIVV Natural